| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | 1.32e-03 | 538 | 9 | 3 | GO:0007264 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | 8.68e-03 | 333 | 9 | 2 | GO:0051056 | |
| Coexpression | GLI1_UP.V1_UP | 2.88e-05 | 24 | 9 | 2 | M2628 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.44e-06 | 140 | 9 | 3 | 7cc891d676555609add6fc7880735d948a2ad801 | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_macrophage|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.81e-06 | 197 | 9 | 3 | e3349a381723393cd255f202afedd0c99037939b | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_macrophage-macrophage|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.81e-06 | 197 | 9 | 3 | e567886d69c6ea8dec87019c2ebc593793cb3107 | |
| ToppCell | Int-URO-Other-RBC|Int-URO / Disease, Lineage and Cell Type | 3.97e-04 | 151 | 9 | 2 | 0344d482f1c55c9eaa15beb8d6bac1c6cdca21b3 | |
| ToppCell | Int-URO-Other|Int-URO / Disease, Lineage and Cell Type | 3.97e-04 | 151 | 9 | 2 | ea5f25842e621be41a6491c9959d419d9cc7ebd6 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.51e-04 | 161 | 9 | 2 | 1e17a993126e1f2a25ee7dfbb95a74ccb2a26791 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.68e-04 | 164 | 9 | 2 | 057ca87847373eff7fe97dd9f4358509e66ca4c3 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-04 | 167 | 9 | 2 | d30b96c39da3dd02500443877a4eb3500e26802c | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-04 | 167 | 9 | 2 | 713899690e4acd9d259645e363c26983d6ef3022 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.85e-04 | 167 | 9 | 2 | d1a13d6ada572d8ddb2da95e6e122d2b705fad7f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.85e-04 | 167 | 9 | 2 | ced6ed9b412739c6ced622523347c10295edbf53 | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.20e-04 | 173 | 9 | 2 | 9a04271c51fae34f547db3206f9ff5857686e45c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.26e-04 | 174 | 9 | 2 | 99eb5e1aee136c7039e23b68a43a0fa3d775859f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.26e-04 | 174 | 9 | 2 | e4d65fe121a32ac4cdd6312e7b8f867f0852e991 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.32e-04 | 175 | 9 | 2 | 12f5fd83c7710fc0c77406f765d9cbd133433b8b | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.32e-04 | 175 | 9 | 2 | 1b4cefae400bf756d09ece32d3f5c0bd4c6ad73f | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.38e-04 | 176 | 9 | 2 | cc6f65a7d2c622841c9d1ab3755586039d4ccc4d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.38e-04 | 176 | 9 | 2 | a4d269075aa0efc46fa251b379f334e50c69391d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.38e-04 | 176 | 9 | 2 | e9152defb4fd41267fb33c42c01fd0c683280783 | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.44e-04 | 177 | 9 | 2 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.44e-04 | 177 | 9 | 2 | ca5a30b3e7bcfdd8de01ceaf7449735b5cd503af | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.44e-04 | 177 | 9 | 2 | cd0684b876c2a7d5fe7e2773e8e25bb61ecbc795 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.44e-04 | 177 | 9 | 2 | 4c069f0d044a96118090b85ca592a21d6b5d9399 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.44e-04 | 177 | 9 | 2 | f471f7747d6e8db7546899019af9508f48a14f89 | |
| ToppCell | Control-Epithelial_alveolar-AT_1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.50e-04 | 178 | 9 | 2 | aa7d43c655df493f1330a5001efaa484e4a19f69 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.50e-04 | 178 | 9 | 2 | 1817bc520f3d23da8c0fa09bba50ae703a820cb1 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.56e-04 | 179 | 9 | 2 | 4f6ca313b78aa93557937a046c44dcf8bcc9963c | |
| ToppCell | AT1_cells-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 5.63e-04 | 180 | 9 | 2 | e1964002681f80d8d62406b6ee52a01e1829ccf2 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage-stroma-monocytoid_macrophage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.63e-04 | 180 | 9 | 2 | ba4c1fb55e8f1095bea6968417fefcf5f700926b | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.69e-04 | 181 | 9 | 2 | 526e858a848470b6d2d5248788004d9735ed3add | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.69e-04 | 181 | 9 | 2 | 0756d7d315b8cdd07a3cf6cdfc8a0679786b8e6a | |
| ToppCell | Mesenchymal_cells-Adipo-CAR|Mesenchymal_cells / Lineage and Cell class | 5.69e-04 | 181 | 9 | 2 | 1cfb03eb03a37b036b4eeacec69c9b8163af1ee4 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.69e-04 | 181 | 9 | 2 | cd81bc307e2bc42c1e9b24d5645ab65fa18c6133 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.69e-04 | 181 | 9 | 2 | a2058d658f07ab6f0a28d2622f3090b4cde6f763 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.69e-04 | 181 | 9 | 2 | 08f44323bf71b6004a921bbc969c954c75feeb66 | |
| ToppCell | droplet-Heart-nan-24m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.69e-04 | 181 | 9 | 2 | 859c40889ede2cbf374c4d2efbb72dc3bc6441f5 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.69e-04 | 181 | 9 | 2 | 3f0d88e9506d66d4e71b88c50d5187302065930f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.69e-04 | 181 | 9 | 2 | 35bcdcd2651149692e5b150e887c0f450c81d2d4 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.69e-04 | 181 | 9 | 2 | b09947d2d7b21f96d98b87ceb6f467ea329c4092 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT1-AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.75e-04 | 182 | 9 | 2 | cc79e0cc21e2fdc4ef77f052818d27b9f707aec1 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.75e-04 | 182 | 9 | 2 | 3d7a8d2ee2137b098248597058974ef5ae09c19e | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.81e-04 | 183 | 9 | 2 | ff6dde877659cde9daa3263db0932c9c9ef1adac | |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 5.81e-04 | 183 | 9 | 2 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| ToppCell | COVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.81e-04 | 183 | 9 | 2 | 7b1a385ed54f93bfe85bf0c162e42d05d516b45c | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.88e-04 | 184 | 9 | 2 | cb15d6bae52c5ec251c2235859dc7e65f630ae23 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.88e-04 | 184 | 9 | 2 | cdf6f1c6cce97a7effa0c55959652e2c0b6992b3 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.88e-04 | 184 | 9 | 2 | bde4eaabd3e9bdaed23867d23a919b9d84b52d4b | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.94e-04 | 185 | 9 | 2 | c82eab551f65ecebe6db908eda9f9eb3414693c7 | |
| ToppCell | Control-Epithelial_alveolar|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.94e-04 | 185 | 9 | 2 | 3937e026add96a396122139daf8011cfbc60e75c | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.94e-04 | 185 | 9 | 2 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | remission-CD8+_T_naive|World / disease stage, cell group and cell class | 5.94e-04 | 185 | 9 | 2 | 69304d7dd406ac7e96d51c239d7035a06d88704f | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.94e-04 | 185 | 9 | 2 | 4cfef50aeed5b3000ce5e864a41c13740b8267b1 | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.94e-04 | 185 | 9 | 2 | c3105978d971da7d0fad1a717ee29afee5ed6357 | |
| ToppCell | droplet-Tongue-Unstain-18m-Epithelial-filiform|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.94e-04 | 185 | 9 | 2 | e0c9e92e35fb24351f5347a0768e6aab5add8775 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT1-AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.94e-04 | 185 | 9 | 2 | 3bef59cc0aa939d2a7e52f0f6c61bc00528fe50b | |
| ToppCell | (1)_Control_(PBS)-(2)_LEPR+_perivascular_cells_and_VE-Cad+_vascular_cells_(mixed)|World / Stress and Cell class | 5.94e-04 | 185 | 9 | 2 | b8cd94cf18308b514fc61557550225794ffd2860 | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.94e-04 | 185 | 9 | 2 | 09256c6f42f59b7eb89160b2ea706172a5b743be | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.00e-04 | 186 | 9 | 2 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | P28-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell_of_alveolus|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.00e-04 | 186 | 9 | 2 | 375642f353842184792a834361284d6897c728de | |
| ToppCell | (0)_MSCs-(00)_Lepr-MSC|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 6.00e-04 | 186 | 9 | 2 | f0d156167d7cc2cd8a76e5a364233e9f2170bc01 | |
| ToppCell | (0)_MSCs|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 6.00e-04 | 186 | 9 | 2 | a832c1e0035bcd559722eccf262c145deb3494c7 | |
| ToppCell | Mesenchymal_cells-Adipo-CAR|World / Lineage and Cell class | 6.00e-04 | 186 | 9 | 2 | 6ca8ce7ced91d6308b7c056032ffec1b37c974bf | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.00e-04 | 186 | 9 | 2 | 9d6cb36aa0aae69fe584dad31deafcfdcc9fd1db | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.07e-04 | 187 | 9 | 2 | ac8e092b37e042975e2ee057d3f7c6821e58e8b5 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.07e-04 | 187 | 9 | 2 | d591a3c216997663ab77710fed0d230ffc37e41a | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.07e-04 | 187 | 9 | 2 | 201ff693e4756ee3e44762885b3a303a77eb535b | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 6.07e-04 | 187 | 9 | 2 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | AT1_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 6.07e-04 | 187 | 9 | 2 | f1dda349335e08dbfc8395d373924037f5ad2fd6 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.07e-04 | 187 | 9 | 2 | d1dc8c9a2c2cd10c640257161a75e7730ec5bb41 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.07e-04 | 187 | 9 | 2 | 7abc174a06bf07b5f6efe0a370fbb1c23e0079b3 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.07e-04 | 187 | 9 | 2 | b0a2e417b4eb9a185033e89c5df3431c11488688 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.07e-04 | 187 | 9 | 2 | d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.07e-04 | 187 | 9 | 2 | f9863428943b695f26bd680e6fc5aeb38ec3422f | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.13e-04 | 188 | 9 | 2 | 43a0508d2524a5b310e89e9422843dcaab999bc3 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.13e-04 | 188 | 9 | 2 | 6164d467b612767ceba15de34176bcc8e8c36ab8 | |
| ToppCell | P15-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell_of_alveolus|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.13e-04 | 188 | 9 | 2 | c0a03e33027f52b5c25ffbc8f822128e5160ed20 | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.13e-04 | 188 | 9 | 2 | 8f6b45ad82bde65e044d17f0edbc3db90d457915 | |
| ToppCell | LAM-Endothelial-VasEndo-1|Endothelial / Condition, Lineage and Cell class | 6.13e-04 | 188 | 9 | 2 | f24c33d960ca93459584a79ff8f0ec20db6a34d5 | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 6.13e-04 | 188 | 9 | 2 | 88b3415e33db81726dd29c1f50c886e057af50a0 | |
| ToppCell | droplet-Fat-Scat-21m-Endothelial-Cd36+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.13e-04 | 188 | 9 | 2 | 8671fdbc4138e6f9559920779c98628ed80f0da3 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 6.20e-04 | 189 | 9 | 2 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-04 | 189 | 9 | 2 | 199cec36fbbc1288771b9edf22143c34ab990af1 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-04 | 189 | 9 | 2 | d52fc275976a625b014fa36f62ef07dddf1ffa43 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.26e-04 | 190 | 9 | 2 | 61f2f9fb4b8f47a2a669f6b052214d2ce0c194cd | |
| ToppCell | droplet-Fat-Scat-21m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.26e-04 | 190 | 9 | 2 | dd89ef1ecea20b2f6fbdc6cea4ca41b28b3ed822 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.26e-04 | 190 | 9 | 2 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.26e-04 | 190 | 9 | 2 | 38a815abf0ac5cac6071737cadc54a514f62d37d | |
| ToppCell | facs-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.26e-04 | 190 | 9 | 2 | 52213cd2a6a20772d4f49ba9ac0407abafa528db | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.26e-04 | 190 | 9 | 2 | bb1476b44dd49e1dd52a636a91c4600b6d4fbe2e | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.26e-04 | 190 | 9 | 2 | f98e2d45fab7d9e16629d7f13cc2ccfb939ef4dd | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-filiform|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.26e-04 | 190 | 9 | 2 | 8a53f4d3c9aca45b5826f53f7dcdfb8bc8280acb | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.26e-04 | 190 | 9 | 2 | d180205c70b5ca9bc5a01a2e6cb42fcebc7f630d | |
| ToppCell | (1)_Control_(PBS)-(3)_LEPR+_perivascular_cells|World / Stress and Cell class | 6.26e-04 | 190 | 9 | 2 | ec0ab31266583a0966ac7615d5c0fabb7b7e66e8 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.26e-04 | 190 | 9 | 2 | 1ff2295c9fc94ea21fff286706b739d0deb032d0 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.26e-04 | 190 | 9 | 2 | d415c8f3d69a8142e95307aeabc6d0e812cd5165 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.26e-04 | 190 | 9 | 2 | 8ceb327dc995f4b83b05d5d6630e1294f0cb49bd | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.26e-04 | 190 | 9 | 2 | 0a211e7dc515926b488f04c6248f6c7e61c2da87 | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-filiform|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.26e-04 | 190 | 9 | 2 | 86ab845a7fae2111c0b01e1aec235e19c4c0ef5c | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.26e-04 | 190 | 9 | 2 | 2d54fca50593fbd11fe13fc2bfaf937a05db776d | |
| ToppCell | droplet-Fat-Scat-21m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.26e-04 | 190 | 9 | 2 | d3e46cf800a07ca9b01c78192962d223b9785d05 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; HL60; HT_HG-U133A | 3.88e-05 | 179 | 9 | 3 | 1175_DN | |
| Drug | Dipivefrin hydrochloride [64019-93-8]; Up 200; 10.4uM; HL60; HG-U133A | 3.94e-05 | 180 | 9 | 3 | 1752_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 10000uM; MCF7; HG-U133A | 4.49e-05 | 188 | 9 | 3 | 345_DN | |
| Drug | STOCK1N-35874; Up 200; 14uM; PC3; HT_HG-U133A | 5.00e-05 | 195 | 9 | 3 | 6561_UP | |
| Drug | Parbendazole [14255-87-9]; Up 200; 16.2uM; PC3; HT_HG-U133A | 5.08e-05 | 196 | 9 | 3 | 4535_UP | |
| Drug | Mafenide hydrochloride [138-37-4]; Up 200; 18uM; HL60; HG-U133A | 5.16e-05 | 197 | 9 | 3 | 1441_UP | |
| Drug | Vitamin K2 [11032-49-8]; Down 200; 9uM; PC3; HT_HG-U133A | 5.16e-05 | 197 | 9 | 3 | 3798_DN | |
| Drug | vinblastine sulfate; Up 200; 0.1uM; MCF7; HT_HG-U133A | 5.16e-05 | 197 | 9 | 3 | 7551_UP | |
| Drug | 5253409; Down 200; 17uM; MCF7; HT_HG-U133A_EA | 5.24e-05 | 198 | 9 | 3 | 961_DN | |
| Drug | Betaxolol hydrochloride [63659-19-8]; Up 200; 11.6uM; PC3; HT_HG-U133A | 5.24e-05 | 198 | 9 | 3 | 4608_UP | |
| Drug | pantogab | 1.37e-03 | 601 | 9 | 3 | ctd:C016030 | |
| Drug | nimodipine | 1.41e-03 | 145 | 9 | 2 | CID000004497 | |
| Drug | Lycorine hydrochloride [2188-68-3]; Up 200; 12.4uM; HL60; HT_HG-U133A | 1.57e-03 | 153 | 9 | 2 | 2195_UP | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.91e-03 | 169 | 9 | 2 | 5572_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.93e-03 | 170 | 9 | 2 | 1050_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.93e-03 | 170 | 9 | 2 | 5417_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.95e-03 | 171 | 9 | 2 | 7407_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 1.95e-03 | 171 | 9 | 2 | 1234_DN | |
| Drug | lavendustin A | 1.95e-03 | 171 | 9 | 2 | CID000003894 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.97e-03 | 172 | 9 | 2 | 7179_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.97e-03 | 172 | 9 | 2 | 1072_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.97e-03 | 172 | 9 | 2 | 6993_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.97e-03 | 172 | 9 | 2 | 2794_DN | |
| Drug | cytochalasin B; Up 200; 20.8uM; MCF7; HT_HG-U133A_EA | 2.00e-03 | 173 | 9 | 2 | 1122_UP | |
| Drug | SAHA; Down 200; 10uM; HL60; HT_HG-U133A | 2.04e-03 | 175 | 9 | 2 | 1161_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.04e-03 | 175 | 9 | 2 | 7387_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.04e-03 | 175 | 9 | 2 | 6316_DN | |
| Drug | Rifabutin [72559-06-9]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 2.04e-03 | 175 | 9 | 2 | 3873_DN | |
| Drug | MG-262; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.06e-03 | 176 | 9 | 2 | 7063_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.06e-03 | 176 | 9 | 2 | 1212_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.06e-03 | 176 | 9 | 2 | 6784_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 2.09e-03 | 177 | 9 | 2 | 1645_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.09e-03 | 177 | 9 | 2 | 6972_DN | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; PC3; HT_HG-U133A | 2.09e-03 | 177 | 9 | 2 | 4652_DN | |
| Drug | 15d-PGJ2; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 2.09e-03 | 177 | 9 | 2 | 1069_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.11e-03 | 178 | 9 | 2 | 1112_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.11e-03 | 178 | 9 | 2 | 1672_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.13e-03 | 179 | 9 | 2 | 6609_DN | |
| Drug | trichostatin A; Down 200; 0.1uM; MCF7; HG-U133A | 2.13e-03 | 179 | 9 | 2 | 332_DN | |
| Drug | trichostatin A; Down 200; 0.1uM; MCF7; HG-U133A | 2.13e-03 | 179 | 9 | 2 | 331_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.16e-03 | 180 | 9 | 2 | 3688_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.16e-03 | 180 | 9 | 2 | 5511_DN | |
| Drug | SAHA; Down 200; 10uM; HL60; HT_HG-U133A | 2.16e-03 | 180 | 9 | 2 | 2680_DN | |
| Drug | STOCK1N-35215; Up 200; 10uM; PC3; HT_HG-U133A | 2.20e-03 | 182 | 9 | 2 | 6427_UP | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 10uM; MCF7; HT_HG-U133A | 2.20e-03 | 182 | 9 | 2 | 3630_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 2.25e-03 | 184 | 9 | 2 | 7555_DN | |
| Drug | Mitoxantrone dihydrochloride [70476-82-3]; Down 200; 7.8uM; PC3; HT_HG-U133A | 2.25e-03 | 184 | 9 | 2 | 6755_DN | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 10uM; MCF7; HT_HG-U133A | 2.28e-03 | 185 | 9 | 2 | 4755_DN | |
| Drug | LY 294002; Down 200; 10uM; HL60; HT_HG-U133A | 2.30e-03 | 186 | 9 | 2 | 6198_DN | |
| Drug | Methotrexate [59-05-2]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 2.33e-03 | 187 | 9 | 2 | 5419_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.33e-03 | 187 | 9 | 2 | 6671_DN | |
| Drug | AH23848 hemicalcium salt hydrate; Up 200; 1uM; PC3; HT_HG-U133A | 2.35e-03 | 188 | 9 | 2 | 6885_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HG-U133A | 2.35e-03 | 188 | 9 | 2 | 1421_DN | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 10uM; PC3; HT_HG-U133A | 2.37e-03 | 189 | 9 | 2 | 3733_DN | |
| Drug | Sparteine (-) [90-39-1]; Down 200; 17uM; MCF7; HT_HG-U133A | 2.37e-03 | 189 | 9 | 2 | 2790_DN | |
| Drug | colcemid; Up 200; 11.7uM; MCF7; HT_HG-U133A_EA | 2.40e-03 | 190 | 9 | 2 | 1103_UP | |
| Drug | resveratrol; Down 200; 50uM; MCF7; HG-U133A | 2.40e-03 | 190 | 9 | 2 | 622_DN | |
| Drug | Estradiol-17 beta [50-28-2]; Down 200; 14.6uM; PC3; HT_HG-U133A | 2.40e-03 | 190 | 9 | 2 | 6718_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A | 2.40e-03 | 190 | 9 | 2 | 1306_DN | |
| Drug | Pempidine tartrate [546-48-5]; Down 200; 13uM; PC3; HT_HG-U133A | 2.40e-03 | 190 | 9 | 2 | 4307_DN | |
| Drug | Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A | 2.42e-03 | 191 | 9 | 2 | 4283_DN | |
| Drug | Cinchonine [118-10-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 2.42e-03 | 191 | 9 | 2 | 2789_DN | |
| Drug | 3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Down 200; 13.8uM; PC3; HT_HG-U133A | 2.42e-03 | 191 | 9 | 2 | 4298_DN | |
| Disease | Tetralogy of Fallot | 2.89e-06 | 10 | 8 | 2 | HP_0001636 | |
| Disease | alcohol dependence | 1.05e-03 | 183 | 8 | 2 | MONDO_0007079 | |
| Disease | type 1 diabetes mellitus | 1.82e-03 | 242 | 8 | 2 | MONDO_0005147 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LWICLICGHIGCGRY | 326 | Q7Z569 | |
| ILVCVCWVGGFLCYP | 161 | Q8NGC7 | |
| CICCGLIWLLDYGSR | 1076 | Q96RV3 | |
| LICAHVCICVGWLYL | 36 | Q8WWI1 | |
| LGAVCGVVLYCACWH | 871 | O14786 | |
| WCHCLYGRQGAAVPL | 471 | Q5K4E3 | |
| LWRVCCIEGIYKGHC | 66 | Q9UBN1 | |
| CLLGHCYGLWFLCLP | 766 | O75064 | |
| GHGIPWLLGTLYCLC | 141 | Q8IY26 |